Practice question

Answer the question and get instant feedback.

ModerateNephrologyCKD Risk Stratificationus-abimus-abfmus-usmle-step-2

A 64-year-old with HFrEF (EF 32%) on ARNI, beta-blocker, MRA, and SGLT2i remains euvolemic. He asks about salt intake and BP targets for kidney protection. What CKD staging element also guides risk discussion and ACEI/ARB therapy?

Educational content. Not a substitute for clinical judgement or local policy.